Search for

Search Results

44 Search Results

Early Detection Is Possible for Pancreatic Cancer

We can help people at risk, but it is much more challenging if most people think that early detection and prevention are impossible. Pancreatic cancer has a bad reputation. It is a terrible disease, but most people do not realize there are ways that early detection can help. When the “Jeopardy!” host, Alex Trebek, announced […]

Researchers ID gene that may predict pancreatic cancer in people with Type 2 diabetes

ROCHESTER, Minn. — Mayo Clinic researchers have identified a gene called “UCP-1” that may predict the development of pancreatic cancer in people with Type 2 diabetes. Their findings are published in Gastroenterology. “Developing strategies for the early detection of pancreatic cancer in people without symptoms is critical for improving survival,” says Suresh Chari, M.D., a Mayo […]

Could Losing Weight Lower My Risk of Cancer?

ACCORDING TO THE LATEST data released by the American Cancer Society, cancer deaths have declined by more than one-quarter (27 percent) over a 25-year span, from 1991 to 2016. But countering that trend, obesity-related cancer is increasing. Previous research indicates that, as noted in the ACS’ Cancer Facts & Figures 2019 report: “An estimated 5% […]

Tackling tumor scar tissue could be key to treating pancreatic cancer

The research, led by Queen Mary University of London, The Institute of Cancer Research, London, Beaujon University Hospital (INSERM), Paris, and Barts Health NHS Trust, could lead to tailor-made treatments, including immunotherapies, which target the powerful scar tissue wall that protects the cancer and makes it such a difficult disease to treat. Co-lead researcher Professor […]

BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer

BioLineRx Ltd. (NASDAQ: BLRX) (TASE:BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead oncology candidate, BL-8040, for the treatment of pancreatic cancer. “Orphan Drug Designation in pancreatic cancer is a very important milestone in the development plan of […]